You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chromatography, Liquid

Showing 1 - 25 of 3,910
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor

Enrolling by invitation
  • Cystic Fibrosis
    • Denver, Colorado
    • +1 more
    Apr 7, 2023

    Opioid Use, Unspecified Trial in Zurich (Fentanyl)

    Recruiting
    • Opioid Use, Unspecified
    • Zurich, Switzerland
      University's Children Hospital
    Feb 13, 2023

    OSCC Identified By Liquid Chromatography Mass Spectroscopy

    Recruiting
    • Oral Squamous Cell Carcinoma
    • Oral Squamous Cell Carcinoma
    • Dhaka, Dhanmondi, Bangladesh
    • +1 more
    Feb 20, 2022

    Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

    Not yet recruiting
    • Lymphoma, B-Cell
    • +6 more
    • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
    • Guayaquil, Guayas, Ecuador
      Instituto Oncológico Nacional Dr. Juan Tanca Marengo
    Apr 27, 2023

    Type 2 Diabetes Mellitus Combined With Acute Myocardial

    Completed
    • STEMI
    • liquid chromatography-mass spectrometry (LC/MS) analysis
    • Beijing, Beijing, China
      Weiping Li
    Oct 26, 2022

    Healthy Volunteers of Fanconi Anemia, Myeloproliferative

    Completed
    • Chronic Myeloproliferative Disorders
    • +3 more
    • microarray analysis
    • +8 more
    • Portland, Oregon
      Knight Cancer Institute at Oregon Health and Science University
    Jun 30, 2022

    Sickle Cell Disease, Sickle Cell Trait, Beta-Thalassemia Trial (High performance liquid chromatography, Automated sickling test,

    Not yet recruiting
    • Sickle Cell Disease
    • +4 more
    • High performance liquid chromatography
    • +5 more
    • (no location specified)
    Aug 17, 2022

    Bilirubin Molecular Species in Hepatic Encephalopathy and

    Recruiting
    • Hepatic Encephalopathy
    • Acute-On-Chronic Liver Failure
    • Liquid Chromatography-Mass Spectrometry Method to identify bilirubin molecular species
    • Mexico City, Mexico
      Medica Sur Clinic & Foundation Organization
    Oct 5, 2022

    Lower Extremity Arterial Disease in Patiens Withe Type 2

    Recruiting
    • Diabetic Angiopathies
    • Diabetes Mellitus, Type 2
    • liquid chromatography-mass spectrometry
    • Chongqing, Chongqing, China
      The third hospital affiliated to the Third Military Medical Univ
    Sep 25, 2021

    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

    Terminated
    Has Results
    • Clear Cell Renal Cell Carcinoma
    • +3 more
    • Buffalo, New York
    • +1 more
    Aug 11, 2022

    Coronary Artery Disease (CAD), Ischemic Heart Disease Trial in United States (Flurpiridaz (18F) Injection)

    Completed
    • Coronary Artery Disease (CAD)
    • Ischemic Heart Disease
    • Flurpiridaz (18F) Injection
    • Hialeah, Florida
    • +4 more
    Jun 9, 2022

    Diabetes, Pre-diabetes Trial in Taichung (Liquid chromatography-mass spectrometry (LC-MS) analysis)

    Recruiting
    • Diabetes Mellitus
    • Pre-diabetes
    • Liquid chromatography-mass spectrometry (LC-MS) analysis
    • Taichung, Taiwan
      China Medical University Hospital
    May 26, 2021

    Tamoxifen in Breast Cancer and in Women at High-Risk of Breast

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • citalopram hydrobromide
    • +10 more
    • Indianapolis, Indiana
    • +3 more
    Feb 18, 2022

    Gonadal Function in Young to Middle Aged HIV-infected Men

    Completed
    • Human Immunodeficiency Virus
    • +2 more
    • No intervention is provided
    • Modena, Italy
      Azienda Ospedaliero - Universitaria di Modena
    Feb 8, 2021

    Serum Metabolomics Study of Polycystic Ovary Syndrome

    Unknown status
    • Polycystic Ovary Syndrome
      • Harbin, Heilongjiang, China
        First Affiliated Hospital, Heilongjiang University of Chinese Me
      Mar 19, 2020

      Mild Cognitive Impairment and Alzheimer's Disease

      Recruiting
      • Alzheimer Disease, Early Onset
      • Protein; Disease
        • Guangzhou, Guangdong, China
          Guangdong Province Hospital of Tradtional Chinese Medicine
        Nov 14, 2022

        CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in

        Not yet recruiting
        • Polymorphism, Genetic
        • +5 more
          • (no location specified)
          Nov 3, 2023

          Lactate Metabolism in the Hypoperfused Critically Ill

          Recruiting
          • Lactate
          • +4 more
          • Blood and urine test
          • Hvidovre, Hovedstaden, Denmark
            Hvidovre University Hospital
          Oct 12, 2022

          Validation of Drug Assays in Various Biological Matrices

          Recruiting
          • Infection
          • antivirals, antimicrobials, oral contraceptive, erectile dysfunction agents
          • Liverpool, United Kingdom
            Royal Liverpool & Broadgreen Univeristy Hospitals NHS Trust
          Nov 1, 2022

          Bruxism Trial

          Not yet recruiting
          • Bruxism
            • (no location specified)
            Oct 14, 2023

            Lymphoma Trial in Portland (biological, drug, genetic, other)

            Terminated
            Has Results
            • Lymphoma
            • rituximab
            • +7 more
            • Portland, Oregon
              Knight Cancer Institute at Oregon Health and Science University
            Nov 15, 2019

            Intestinal Flora and Metabonomics of Appendicitis

            Recruiting
            • Appendicitis
            • +2 more
              • Jinan, Shandong, China
                The First Affiliated Hospital Of Shandong First Medcial Unversit
              Sep 5, 2023

              Solid Tumor Trial in Hamilton, Toronto (HDAC inhibitor SB939, immunoenzyme technique, immunohistochemistry staining method)

              Completed
              • Unspecified Adult Solid Tumor, Protocol Specific
              • HDAC inhibitor SB939
              • +7 more
              • Hamilton, Ontario, Canada
              • +1 more
              Apr 6, 2020

              Post-infection Irritable Bowel Syndrome

              Not yet recruiting
              • Post-infectious Irritable Bowel Syndrome
              • Irritable Bowel Syndrome
                • (no location specified)
                Sep 7, 2023

                Solid Tumor Trial in Duarte (other, procedure, radiation)

                Completed
                • Unspecified Adult Solid Tumor, Protocol Specific
                • high performance liquid chromatography
                • +4 more
                • Duarte, California
                  City of Hope Comprehensive Cancer Center
                Feb 25, 2020